TACSTD2 and adenocarcinoma: Study of TROP2 CAR–engineered IL‐15–transduced cord blood–derived NK cells delivered intraperitoneally for the management of platinum resistant ovarian cancer, mesonephric‐like adenocarcinoma, and pancreatic cancer